Wisconsin SB 783: Relating to: therapeutic interchange for drug products prescribed to counteract anaphylaxis.

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2024-04-15)

State: Wisconsin · Session: 2023 · Bill: SB 783

Sponsors: Smith, Spreitzer, Taylor, Wirch

View Wisconsin SB 783 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.